Discontinuation report VIZIMPRO

Last updated on 2023-01-14 History
Report ID 180953
Drug Identification Number 02486032
Brand name VIZIMPRO
Common or Proper name VIZIMPRO
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DACOMITINIB
Strength(s) 30MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30's
ATC code L01XE
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2023-01-13
Remaining supply date 2023-01-13
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2023-01-14 English Compare
v2 2023-01-13 French Compare
v1 2023-01-13 English Compare

Showing 1 to 3 of 3